List of insiders holdings for RenovoRx Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
# | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
1 | Najmabadi Kamran Najmabadi Family Trust dated April 22 2021 10% Owner | 2022-02-14 06:33:04 | 1,045,000 0 | 1,045,000 | Form 13G |
2 | BANK OF THE WEST 10% Owner | 2022-04-14 14:46:59 | 0 975,000 | 975,000 | Form 3 |
3 | Bagai Shaun Chief Executive Officer | 2025-08-26 06:10:14 | 330,040 0 | 330,040 | Form 4 |
4 | Nelms Angela Chief Operating Officer | 2024-01-23 21:50:30 | 158,900 0 | 158,900 | Form 4 |
5 | Marton Laurence Director | 2025-05-06 16:10:20 | 66,164 0 | 66,164 | Form 4 |
6 | Agah Ramtin Chief Medical Officer | 2025-07-03 16:45:34 | 63,636 0 | 63,636 | Form 4 |
7 | Kocak Ron VP, Controller and PAO | 2025-07-03 16:45:30 | 41,600 0 | 41,600 | Form 4 |
8 | Manners Paul Chief Financial Officer | 2021-08-25 17:26:41 | 27,999 0 | 27,999 | Form 3 |
9 | Diamond David Director | 2023-10-02 16:15:49 | 25,099 0 | 25,099 | Form 4 |
10 | Spiegel Robert J. Director | 2024-10-02 16:30:15 | 25,099 0 | 25,099 | Form 4 |
11 | Macfarlane K. Angela Director | 2024-10-02 16:30:18 | 25,099 0 | 25,099 | Form 4 |
12 | RYAN UNA S Director | 2024-10-02 16:30:19 | 25,099 0 | 25,099 | Form 4 |
13 | Gentry Leesa Chief Clinical Officer | 2025-07-03 16:45:31 | 6,619 0 | 6,619 | Form 4 |
14 | Lehman Christopher John Chief Financial Officer | 2021-08-30 11:06:51 | 0 0 | 0 | Form 3 |
15 | Ahlers James M Chief Financial Officer | 2022-07-20 16:05:24 | 0 0 | 0 | Form 3 |